Rebalix
iShares · sheet of 20 October 2026
iShares · sheet of 20 October 2026ETF sheet · official issuer and register data
iShares EUR Inflation Linked Govt Bond UCITS ETF
IBCI · IE00B0M62X26 · EUR · domicile Ireland
Bonds · Inflation-linked EUR · Broad (all maturities) · Eurozone
Index tracked: BBG Euro Government Inflation-Linked Bond Index (EUR)
- TER
- 0.09%+ trans. 0.00%
- Fund size
- 1.9 bn EUR
- Tracking difference
- −0.06%3-year avg
- 🇮🇹 tax rate
- 12.61%white list 99.20%
- Replication
- Physical (optimised)
- Income
- Accumulating
- Duration
- 7.07 yrslong (>7 years)
Launch 18 Nov 2005 · costs from the KID as of 4 Aug 2026 · 39 securities held · 12 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Oct 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return on the Government inflation-linked bonds issued by European Economic and Monetary Union (EMU) member states. The Fund aims to produce a return on your investment which reflects the return of the Bloomberg Euro Government Inflation Linked Bond Index, the Fund’s benchmark index (Index). The Share Class, via the Fund is passively managed and aims to invest so far as…
Performance since series start (in euro) — base 100
18 Nov 2005 → 16 Oct 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | −0.7% |
| 3 years | +6.6% |
| 5 years | −2.7% |
| 10 years | +11.8% |
| Since series start | +48.4% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 3.47% | 4.19% | 6.65% |
| Max drawdown | −4.22% | −4.22% | −15.82% |
| Sharpe | -0.81 | -0.18 | -0.44 |
| Sortino | -1.09 | -0.26 | -0.62 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IBCI · IE00B0M62X261
RebalixIBCI · IE00B0M62X26 · sheet of 20 October 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +0.83% | +0.84% | −0.01% |
| 2024 | −0.05% | +0.07% | −0.12% |
| 2023 | +5.88% | +5.93% | −0.05% |
| 2022 | −9.73% | −9.66% | −0.07% |
| 2021 | +6.08% | +6.36% | −0.27% |
Fixed income — as declared by the issuer
Issuer page · 15 Oct 2026 · investment-grade share (BBB−/Baa3 and above): 100.0%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Holdings
Portfolio as declared by the issuer · 30 Sept 2026 · 39 securities · top-10 weight = 41.8%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
IBCI · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Amsterdam, London Stock Exchange, SIX Swiss Exchange, Tradegate Exchange, Xetra (Deutsche Börse)
+ 7 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00B0M62X26
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00B0M62X26
Series, distributions, holdings and documents refresh daily.
Sheet produced on 20 October 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IBCI · IE00B0M62X262